It has been well known that vaso-dilator lipid, prostaglandin (PG), produces an increase of renal blood flow, urinary output and urinary excretion of sodium in animal and man (Johnston et al. 1967; Vander 1968; Lee et al. 1971) . Recently, Lee (1971 Lee ( , 1972 proposed a hypothesis that PGA may be a circulatory natriuretic antihypertensive hormone of renal origin. On the other hand, it has also been suggested that PGE2 may be a modulator of the excretory function of the kidney (Fulgraff et al. 1974 ). In the present study, the effects of prostaglandin on the renal handling of water and electrolytes, and on the secretion of renin have been investigated in various types of hypertension.
MATERIALS AND METHODS
Twenty-six patients with various types of hypertension were included in this study. augmentation beyond 100%. On the other hand, urinary output was decreased in 3 cases (13%) and not changed in the remaining 4 (17%). Increased sodium excre tion was found in 14 cases (61%). A prominent increase was also found in primary aldosteronism. Sodium output was doubled or higher in 5 cases (71%). Urinary excretion of sodium was decreased in only 2 (9%), and no significant change was found in the remaining 7 (30%). Marked increase of potassium excretion was observed in only 4 cases in which 2 belonged to primary aldosteronism. No significant alteration of creatinine clearance was obtained in 13 cases (57%), while the remaining 10 had a slight increment or decrement.
In essential hypertension, the increase of urine volume was found in 6 out of 7 cases and sodium excretion in 4 cases. Similar changes were observed in renovascular hypertension. In primary aldosteronism, augmentation of both fluid volume and urinary sodium was obtained in almost all patients. Fig. 3 demonstrates the average increase ratio of urine volume and sodium excretion in them. The greatest increment among 3 types of hypertension was found in primary aldosteronism (319% in urine volume and 222% in sodium output). On the other hand, essential hypertension had the average increment of 61% in volume and 63% in sodium, and renovascular hypertension, 97% and 56% respec tively.
To investigate the mechanism by which the prominent effect of PGE1 was induced in primary aldosteronism, the same doses of PGE1 were infused intravenously in a case of this disease after the administration of spironolactone 150 mg daily for 14 days. Fig. 4 demonstrates the comparison of the changes of urine volume, urinary sodium excretion and creatinine clearance during PGE1 infusion before and after the administration of spironolactone . Remarkable diuretic and natriuretic effects of PGE1 were abolished after the medication . 
Effect on renin release
Plasma renin activity was measured in 23 cases of various types of hyperten sion. Fig. 5 shows the changes of peripheral vein blood renin activity following infusion. In 8 cases of essential hypertension, marked increase of the activity This question seems to be very important, but it remained unanswered in the present study, because we found no correlation between the changes in renin, water and sodium excretion, and glomerular filtration following the infusion of PGE1.
